Published in Cancer Res on January 01, 1997
A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults. Int J Behav Nutr Phys Act (2010) 4.05
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20
Influence of obesity on the risk of developing colon cancer. Gut (2005) 1.93
A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum (2009) 1.85
Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis (2009) 1.84
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol (2001) 1.79
Obesity and colorectal cancer risk in women. Gut (2002) 1.79
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer (2010) 1.51
An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer (2014) 1.42
BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol (1999) 1.36
IL6 genotypes and colon and rectal cancer. Cancer Causes Control (2007) 1.36
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis (2007) 1.28
Microsatellite instability and survival in rectal cancer. Cancer Causes Control (2009) 1.24
Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer (2010) 1.22
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res (2008) 1.18
Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer (2003) 1.18
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res (2010) 1.17
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog (2011) 1.16
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Physical activity and risk of cancer in middle-aged men. Br J Cancer (2001) 1.15
Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer (2011) 1.12
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway. Carcinogenesis (2010) 1.11
Leisure-time physical activity patterns and risk of colon cancer in women. Int J Cancer (2007) 1.10
The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer (2008) 1.10
MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis (2016) 1.08
MAP kinase genes and colon and rectal cancer. Carcinogenesis (2012) 1.08
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis (2011) 1.05
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer. Mutat Res (2010) 1.04
CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.04
Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer (2008) 1.04
Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. Eur J Cancer Prev (2008) 1.04
Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer (2009) 1.03
Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa. Clin Transl Gastroenterol (2016) 1.03
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer (2010) 1.02
Estimating the heritability of colorectal cancer. Hum Mol Genet (2014) 1.02
Does physical activity prevent cancer? Evidence suggests protection against colon cancer and probably breast cancer. BMJ (2000) 1.00
Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer (2011) 0.99
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Med Genet (2010) 0.99
Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. Mutat Res (2012) 0.99
A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev (2012) 0.97
Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer (2009) 0.97
Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet (2014) 0.96
Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control (2010) 0.94
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer (2011) 0.92
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control (2013) 0.92
Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res (2012) 0.91
Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study. Int J Mol Epidemiol Genet (2012) 0.91
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev (2015) 0.90
Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer (2013) 0.89
Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control (2011) 0.89
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89
Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer (2012) 0.88
Comparative efficacy of 5flourouracil/calcium leucovorine versus 5flourouracil/calcium leucovorine plus oxaliplatin in the adjuvant treatment of colonic carcinoma in Kashmir. South Asian J Cancer (2013) 0.88
Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring) (2008) 0.87
TERT's role in colorectal carcinogenesis. Mol Carcinog (2012) 0.86
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer. PLoS One (2012) 0.86
Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum (2012) 0.86
Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Nutr Cancer (2010) 0.86
A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst (2015) 0.86
Tumor necrosis factor-related genes and colon and rectal cancer. Int J Mol Epidemiol Genet (2011) 0.85
Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet (2013) 0.85
Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet (2010) 0.85
PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr (2012) 0.85
Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression. PLoS One (2014) 0.84
Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis. Mod Pathol (2016) 0.84
Site-specific associations between miRNA expression and survival in colorectal cancer cases. Oncotarget (2016) 0.83
Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer (2013) 0.83
Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol (2015) 0.83
Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum (2010) 0.82
The Association between Polymorphismsin Insulin and Obesity Related Genesand Risk of Colorectal Cancer. Iran J Cancer Prev (2013) 0.82
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog (2009) 0.82
Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol (2011) 0.82
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis (2015) 0.81
A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer. Carcinogenesis (2014) 0.81
Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer (2012) 0.81
Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Nutr Cancer (2011) 0.80
Changing population characteristics, effect-measure modification, and cancer risk factor identification. Epidemiol Perspect Innov (2007) 0.80
The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach. Curr Nutr Rep (2013) 0.80
Association of leptin receptor gene Gln223Arg polymorphism with susceptibility to colorectal cancer. Gastroenterol Hepatol Bed Bench (2011) 0.79
Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study. BMC Med Genomics (2016) 0.79
Diet and lifestyle factors associated with miRNA expression in colorectal tissue. Pharmgenomics Pers Med (2016) 0.78
Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.78
Dietary intake alters gene expression in colon tissue: possible underlying mechanism for the influence of diet on disease. Pharmacogenet Genomics (2016) 0.77
The influence of the CHIEF pathway on colorectal cancer-specific mortality. PLoS One (2014) 0.77
Obesity as an important risk factor for certain types of cancer. Iran J Cancer Prev (2013) 0.76
SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk. PLoS One (2015) 0.76
Recent advances in the link between physical activity, sedentary behavior, physical fitness, and colorectal cancer. F1000Res (2017) 0.75
Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue. Oncotarget (2017) 0.75
Telomere Length, TERT, and miRNA Expression. PLoS One (2016) 0.75
Molecular epidemiology of colon cancer. Cancer Res Treat (2004) 0.75
Alterations in microRNA expression associated with alcohol consumption in rectal cancer subjects. Cancer Causes Control (2017) 0.75
The miRNA Landscape of Colorectal Polyps. Genes Chromosomes Cancer (2016) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
Genetic inheritance of gene expression in human cell lines. Am J Hum Genet (2004) 8.97
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens (1999) 6.74
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med (2000) 6.53
Eating patterns and risk of colon cancer. Am J Epidemiol (1998) 6.08
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 5.92
Expression of flagellar genes carried by bacteriophage lambda. Nature (1976) 5.14
The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell (1996) 5.10
Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev (2000) 4.51
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst (2000) 4.39
On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol (1983) 4.35
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Monitoring clinical trials--interim data should be publicly available. BMJ (2001) 4.20
Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature (1998) 4.18
CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell (1991) 4.05
Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation (1992) 3.98
Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine (1998) 3.16
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis (1994) 3.05
The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc (1991) 3.04
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
Genes, themes and microarrays: using information retrieval for large-scale gene analysis. Proc Int Conf Intell Syst Mol Biol (2000) 3.01
Bacterial community dynamics across a floristic gradient in a temperate upland grassland ecosystem. Microb Ecol (2002) 2.99
Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med (1998) 2.58
The bases of practice--neurological physiotherapy. Physiother Res Int (1996) 2.52
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity (2001) 2.49
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat Genet (1997) 2.28
Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol (1994) 2.28
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Mycobacterium bovis infection in human beings in contact with elk (Cervus elaphus) in Alberta, Canada. Lancet (1991) 2.20
Prophylactic nasogastric decompression after abdominal surgery. Cochrane Database Syst Rev (2007) 2.18
Is early natural menopause a biologic marker of health and aging? Am J Public Health (1989) 2.16
A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ (2001) 2.11
Molecular cloning and sequence analysis of a haploid expressed gene encoding t complex polypeptide 1. Cell (1986) 2.11
Statistical methods in epidemiology: a comparison of statistical methods to analyze dose-response and trend analysis in epidemiologic studies. J Clin Epidemiol (1998) 2.09
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control (1998) 2.05
Physical activity and colorectal cancer. Am J Epidemiol (2003) 2.04
"Fast tracking" patients with a proximal femoral fracture. J Accid Emerg Med (1996) 1.99
Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) (1982) 1.91
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer (2011) 1.86
A prospective cohort of American Indian and Alaska Native people: study design, methods, and implementation. Am J Epidemiol (2007) 1.86
Comparison of the Block and the Willett self-administered semiquantitative food frequency questionnaires with an interviewer-administered dietary history. Am J Epidemiol (1998) 1.85
Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82
Behavioral responses to artificial food colors. Science (1980) 1.82
Rethinking sexual health clinics. Patients prefer clinics to have non-descriptive titles. BMJ (1995) 1.81
Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control (1997) 1.75
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc (1994) 1.70
Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res (2001) 1.67
The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia (2006) 1.65
Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer (1993) 1.64
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer (2012) 1.64
Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst (2001) 1.62
The surgical treatment of hemi-facial spasm. Preliminary report. J Laryngol Otol (1972) 1.61
Contamination of environmental surfaces by genital human papillomaviruses. Sex Transm Infect (2002) 1.60
Contribution of Malate and Amino Acid Metabolism to Cytoplasmic pH Regulation in Hypoxic Maize Root Tips Studied Using Nuclear Magnetic Resonance Spectroscopy. Plant Physiol (1992) 1.59
Specifications for equipment used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J (2000) 1.57
Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev (2002) 1.54
Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol (1996) 1.52
Born too late to win? Nature (1994) 1.51
Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J (2000) 1.51
Patient characteristics affecting attendance at general outpatient clinics. Arch Dis Child (1996) 1.49
General method for isolating de-repressed bacterial sex factors. Nature (1968) 1.47
Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr (2001) 1.46
Inconsistent associations of caffeine-containing beverages with blood pressure and with lipoproteins. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (1993) 1.42
Cloning and expression of bovine brain inositol monophosphatase. J Biol Chem (1990) 1.41
Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control (2000) 1.38
Treatment of advanced squamous cell carcinoma of head and neck with cisplatin and continuous 96 hour infusion of 5-fluorouracil. Aust N Z J Med (1989) 1.38
Systematic review of prophylactic nasogastric decompression after abdominal operations. Br J Surg (2005) 1.38
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer (2008) 1.37
The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother (2009) 1.35
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet (1998) 1.35
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet (2006) 1.35
Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. J Appl Behav Anal (1999) 1.34
Subunit interactions within the Saccharomyces cerevisiae DNA polymerase epsilon (pol epsilon ) complex. Demonstration of a dimeric pol epsilon. J Biol Chem (2000) 1.34
Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res (2000) 1.32
Molecular cloning and expression of a cDNA encoding the rabbit ileal villus cell basolateral membrane Na+/H+ exchanger. EMBO J (1991) 1.31
The effects of exercise training on mood and perceived coping ability in anxious adults from the general population. J Psychosom Res (1989) 1.30
[Comparison of the emergency medical services systems of Birmingham and Bonn: process efficacy and cost effectiveness]. Anasthesiol Intensivmed Notfallmed Schmerzther (2003) 1.27